Eyeberia

Specialisation

Retina and Vitreous

Full title

A 12-month, Prospective, Open-label, Phase 4 Study to Evaluate the Efficacy and Safety of OZURDEX (Dexamethasone Intravitreal Implant) in Treatment Naïve Patients (According to Standard Clinical Practice) with Diabetic Macular Edema

Promoter

ALLERGAN

Start date

November 2019

Researchers

Main: Dr Rafael Navarro

Co-Researchers: Dr Anniken Burés, Dr Borja Corcóstegui, Dr Carlos Mateo, Dr Cecilia Salinas